BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 31281320)

  • 1. Structural Basis of IL-1 Family Cytokine Signaling.
    Fields JK; Günther S; Sundberg EJ
    Front Immunol; 2019; 10():1412. PubMed ID: 31281320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor.
    Fields JK; Kihn K; Birkedal GS; Klontz EH; Sjöström K; Günther S; Beadenkopf R; Forsberg G; Liberg D; Snyder GA; Deredge D; Sundberg EJ
    Front Immunol; 2021; 12():779100. PubMed ID: 35003094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor.
    Günther S; Deredge D; Bowers AL; Luchini A; Bonsor DA; Beadenkopf R; Liotta L; Wintrode PL; Sundberg EJ
    Immunity; 2017 Sep; 47(3):510-523.e4. PubMed ID: 28930661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-36: Structure, Signaling and Function.
    Zhou L; Todorovic V
    Adv Exp Med Biol; 2021; 21():191-210. PubMed ID: 32026417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling.
    Fields JK; Gyllenbäck EJ; Bogacz M; Obi J; Birkedal GS; Sjöström K; Maravillas K; Grönberg C; Rattik S; Kihn K; Flowers M; Smith AK; Hansen N; Fioretos T; Huyhn C; Liberg D; Deredge D; Sundberg EJ
    Cell Rep; 2024 May; 43(5):114099. PubMed ID: 38636519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic human monoclonal antibody targets hIL1 receptor accessory protein chain with therapeutic potential in triple-negative breast cancer.
    Zheng P; Zhang Y; Zhang B; Wang Y; Wang Y; Yang L
    Biomed Pharmacother; 2018 Nov; 107():1064-1073. PubMed ID: 30257318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions.
    Gabay C; Towne JE
    J Leukoc Biol; 2015 Apr; 97(4):645-52. PubMed ID: 25673295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions.
    Zarezadeh Mehrabadi A; Aghamohamadi N; Khoshmirsafa M; Aghamajidi A; Pilehforoshha M; Massoumi R; Falak R
    Immunology; 2022 May; 166(1):38-46. PubMed ID: 35231129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
    Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
    Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687.
    Lu HL; Yang CY; Chen HC; Hung CS; Chiang YC; Ting LP
    Mol Immunol; 2008 Mar; 45(5):1374-84. PubMed ID: 17949817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin-1 receptor family.
    Boraschi D; Tagliabue A
    Semin Immunol; 2013 Dec; 25(6):394-407. PubMed ID: 24246227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
    Chackerian AA; Oldham ER; Murphy EE; Schmitz J; Pflanz S; Kastelein RA
    J Immunol; 2007 Aug; 179(4):2551-5. PubMed ID: 17675517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein.
    Jensen LE; Muzio M; Mantovani A; Whitehead AS
    J Immunol; 2000 May; 164(10):5277-86. PubMed ID: 10799889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses.
    Krumm B; Xiang Y; Deng J
    Protein Sci; 2014 May; 23(5):526-38. PubMed ID: 24677376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-1 family in tumorigenesis and antitumor immunity.
    Sun R; Gao DS; Shoush J; Lu B
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):280-295. PubMed ID: 35580824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes.
    Banerjee M; Saxena M
    Clin Chim Acta; 2012 Aug; 413(15-16):1163-70. PubMed ID: 22521751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
    Dunne A; O'Neill LA
    Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
    Martin MU; Wesche H
    Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.